Vitamin E as a potential interventional treatment for metabolic syndrome

Evidence from animal and human studies

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

A constellation of medical conditions inclusive of central obesity, hyperglycemia, hypertension, and dyslipidemia is known as metabolic syndrome (MetS). The safest option in curtailing the progression of MetS is through maintaining a healthy lifestyle, which by itself, is a long-term commitment entailing much determination. A combination of pharmacological and non-pharmacological approach, as well as lifestyle modification is a more holistic alternative in the management of MetS. Vitamin E has been revealed to possess anti-oxidative, anti-inflammatory, anti-obesity, anti-hyperglycemic, anti-hypertensive and anti-hypercholesterolemic properties. The pathways regulated by vitamin E are critical in the development of MetS and its components. Therefore, we postulate that vitamin E may exert some health benefits on MetS patients. This review intends to summarize the evidence in animal and human studies on the effects of vitamin E and articulate the contrasting potential of tocopherol (TF) and tocotrienol (T3) in preventing the medical conditions associated with MetS. As a conclusion, this review suggests that vitamin E may be a promising agent for attenuating MetS.

Original languageEnglish
Article number444
JournalFrontiers in Pharmacology
Volume8
Issue numberJUL
DOIs
Publication statusPublished - 5 Jul 2017

Fingerprint

Vitamin E
Therapeutics
Tocotrienols
Tocopherols
Abdominal Obesity
Insurance Benefits
Dyslipidemias
Hyperglycemia
Antihypertensive Agents
Life Style
Anti-Inflammatory Agents
Obesity
Pharmacology
Hypertension

Keywords

  • Dyslipidemia
  • Hyperglycemia
  • Hypertension
  • Metabolic syndrome
  • Obesity
  • Tocopherol
  • Tocotrienol
  • Vitamin E

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{cf5ed94d48924dfc9a0b7fe451c21d16,
title = "Vitamin E as a potential interventional treatment for metabolic syndrome: Evidence from animal and human studies",
abstract = "A constellation of medical conditions inclusive of central obesity, hyperglycemia, hypertension, and dyslipidemia is known as metabolic syndrome (MetS). The safest option in curtailing the progression of MetS is through maintaining a healthy lifestyle, which by itself, is a long-term commitment entailing much determination. A combination of pharmacological and non-pharmacological approach, as well as lifestyle modification is a more holistic alternative in the management of MetS. Vitamin E has been revealed to possess anti-oxidative, anti-inflammatory, anti-obesity, anti-hyperglycemic, anti-hypertensive and anti-hypercholesterolemic properties. The pathways regulated by vitamin E are critical in the development of MetS and its components. Therefore, we postulate that vitamin E may exert some health benefits on MetS patients. This review intends to summarize the evidence in animal and human studies on the effects of vitamin E and articulate the contrasting potential of tocopherol (TF) and tocotrienol (T3) in preventing the medical conditions associated with MetS. As a conclusion, this review suggests that vitamin E may be a promising agent for attenuating MetS.",
keywords = "Dyslipidemia, Hyperglycemia, Hypertension, Metabolic syndrome, Obesity, Tocopherol, Tocotrienol, Vitamin E",
author = "Wong, {Sok Kuan} and {Kok Yong}, Chin and Farihah Suhaimi and Fairus Ahmad and Soelaiman, {Ima Nirwana}",
year = "2017",
month = "7",
day = "5",
doi = "10.3389/fphar.2017.00444",
language = "English",
volume = "8",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S. A.",
number = "JUL",

}

TY - JOUR

T1 - Vitamin E as a potential interventional treatment for metabolic syndrome

T2 - Evidence from animal and human studies

AU - Wong, Sok Kuan

AU - Kok Yong, Chin

AU - Suhaimi, Farihah

AU - Ahmad, Fairus

AU - Soelaiman, Ima Nirwana

PY - 2017/7/5

Y1 - 2017/7/5

N2 - A constellation of medical conditions inclusive of central obesity, hyperglycemia, hypertension, and dyslipidemia is known as metabolic syndrome (MetS). The safest option in curtailing the progression of MetS is through maintaining a healthy lifestyle, which by itself, is a long-term commitment entailing much determination. A combination of pharmacological and non-pharmacological approach, as well as lifestyle modification is a more holistic alternative in the management of MetS. Vitamin E has been revealed to possess anti-oxidative, anti-inflammatory, anti-obesity, anti-hyperglycemic, anti-hypertensive and anti-hypercholesterolemic properties. The pathways regulated by vitamin E are critical in the development of MetS and its components. Therefore, we postulate that vitamin E may exert some health benefits on MetS patients. This review intends to summarize the evidence in animal and human studies on the effects of vitamin E and articulate the contrasting potential of tocopherol (TF) and tocotrienol (T3) in preventing the medical conditions associated with MetS. As a conclusion, this review suggests that vitamin E may be a promising agent for attenuating MetS.

AB - A constellation of medical conditions inclusive of central obesity, hyperglycemia, hypertension, and dyslipidemia is known as metabolic syndrome (MetS). The safest option in curtailing the progression of MetS is through maintaining a healthy lifestyle, which by itself, is a long-term commitment entailing much determination. A combination of pharmacological and non-pharmacological approach, as well as lifestyle modification is a more holistic alternative in the management of MetS. Vitamin E has been revealed to possess anti-oxidative, anti-inflammatory, anti-obesity, anti-hyperglycemic, anti-hypertensive and anti-hypercholesterolemic properties. The pathways regulated by vitamin E are critical in the development of MetS and its components. Therefore, we postulate that vitamin E may exert some health benefits on MetS patients. This review intends to summarize the evidence in animal and human studies on the effects of vitamin E and articulate the contrasting potential of tocopherol (TF) and tocotrienol (T3) in preventing the medical conditions associated with MetS. As a conclusion, this review suggests that vitamin E may be a promising agent for attenuating MetS.

KW - Dyslipidemia

KW - Hyperglycemia

KW - Hypertension

KW - Metabolic syndrome

KW - Obesity

KW - Tocopherol

KW - Tocotrienol

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=85025476165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025476165&partnerID=8YFLogxK

U2 - 10.3389/fphar.2017.00444

DO - 10.3389/fphar.2017.00444

M3 - Review article

VL - 8

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

IS - JUL

M1 - 444

ER -